|
2024-11-16 |
7x |
Macropolycytes |
|
2024-10-12 |
5x |
Mastocytosis |
|
2024-09-30 |
9x |
CML |
|
2024-09-28 |
4x |
Crystals of Death |
|
2024-09-01 |
7x |
AML with maturation |
|
2024-07-22 |
14x |
VEXAS syndrome |
|
2024-05-19 |
11x |
Sezary syndrome |
|
2024-04-20 |
15x |
hypoplastic AML |
|
2024-04-08 |
17x |
Babesiosis |
|
2024-03-31 |
14x |
prefibrotic PMF |
|
2024-03-24 |
12x |
Acute Monocytic Leukemia |
|
2024-02-18 |
16x |
Multiple Myeloma with high mitotic index |
|
2024-02-18 |
16x |
Dysmegakaryopoieses |
|
2023-12-25 |
7x |
LPL with abundant Russell bodies |
|
2023-11-14 |
13x |
Plasmodium Malariae |
|
2023-11-06 |
7x |
APL with PML-RARA |
|
2023-10-14 |
3x |
Hairy Cell Leukemia |
|
2023-10-07 |
5x |
Polyklonal B-cell Lymphocytosis |
|
2023-08-27 |
7x |
Dyserythropoiesis |
|
2023-08-19 |
1x |
Pappenheimer bodies, basophilic stippling and Howell Jolly bodies |
|
2023-08-14 |
4x |
Blasts with Auer rods |
|
2023-08-06 |
10x |
Chronic Myeloid Leukemia (CML) |
|
2023-08-05 |
14x |
common B-ALL |
|
2023-07-16 |
9x |
Multiple Myeloma with Russell Bodies |
|
2023-06-20 |
2x |
Myeloblasts |
|
2023-05-22 |
6x |
Follicular lymphoma |
|
2023-05-22 |
10x |
Plasma Cell Myeloma |
|
2023-04-24 |
3x |
Hairy Cell Leukemia |
|
2023-04-05 |
6x |
Plasma Cell Myeloma |
|
2023-02-18 |
14x |
Aggresive NK-cell lymphoma/leukemia |
|
2023-01-02 |
9x |
MDS/MPN – CMML |
|
2022-12-24 |
12x |
Mastocytosis with associated myeloid neoplasm |
|
2022-11-20 |
15x |
Acute Erythroid Leukaemia |
|
2022-10-23 |
14x |
MDS/MPN with ringsideroblasts and thrombocytosis |
|
2022-09-24 |
4x |
Plasmodium Falciparum infection |
|
2022-09-24 |
13x |
Polycythemia Vera |
|
2022-08-15 |
10x |
Bone marrow involvement of ductal pancreas carcinoma |
|
2022-06-04 |
11x |
Bone marrow involvement of Renal cell carcinoma |
|
2022-05-16 |
19x |
CLL in transformation to DLBCL (Richter Transformation) |
|
2022-04-24 |
1x |
Flow cytometry maturation plots monopoiesis |
|
2022-04-03 |
11x |
Dysplastic erythropoiesis |
|
2022-03-13 |
6x |
blood involvement of DLBCL |
|
2022-02-05 |
– |
New consensus recommendation for definition of PCL |
|
2021-11-28 |
10x |
Regeneration after chemotherapy |
|
2021-11-23 |
9x |
AML with NPM1 and FLT3 (ITD) mutation |
|
2021-11-23 |
7x |
AML with inv(16) or t(16;16) |
|
2021-11-22 |
1x |
overview dysplastic features neutrophils |
|
2021-09-24 |
7x |
Splenic diffuse red pulp small B-cell lymphoma |
|
2021-09-12 |
6x |
Mantle Cell Lymphoma |
|
2021-08-16 |
4x |
Sickle cell crisis: phase-contrast |
|
2021-08-16 |
6x |
MDS-MLD |
|
2021-08-07 |
10x |
Dysplastic erythropoiesis |
|
2021-07-04 |
9x |
Dutcher bodies seen in Multiple Myeloma |
|
2021-06-28 |
12x |
Chanarin-Dorfman syndrome |
|
2021-06-21 |
7x |
Dysplasia erythropoiesis update |
|
2021-05-20 |
30x |
Comparing morphology of megakaryocytes |
|
2021-04-06 |
7x |
Grey Platelet Syndrome (GPS) |
|
2021-04-05 |
16x |
Mantle Cell Lymphoma (MCL) |
|
2021-03-29 |
3x |
Basophilic stippling |
|
2021-03-29 |
2x |
Mastocytosis |
|
2021-03-27 |
11x |
Sickle cell crisis |
|
2021-03-20 |
8x |
NK-lymphocytosis / NK-LGL |
|
2021-01-29 |
4x |
added some Dyserythropoiesis |
|
2021-01-23 |
6x |
Plasma Cell Myeloma with amyloidosis |
|
2021-01-21 |
3x |
T-LGL |
|
2020-12-17 |
12x |
Alcohol abuse |
|
2020-12-17 |
6x |
Cold agglutinin disease (CAD) |
|
2020-12-17 |
9x |
Sickle cell anemia |
|
2020-12-17 |
8x |
Thalassemia |
|
2020-12-17 |
10x |
Gastric cancer |
|
2020-12-17 |
10x |
Colorectal carcinoma |
|
2020-12-16 |
27x |
Mantle Cell Lymphoma (MCL) |
|
2020-12-16 |
19x |
LymphoPlasmacytic Lymphoma (LPL) |
|
2020-12-16 |
31x |
AML with dysplastic related changes |
|
2020-12-16 |
16x |
Splenic Marginal Zone Lymphoma (SMZL) |
|
2020-12-16 |
6x |
Lung: Squamous cell carcinoma |
|
2020-12-15 |
15x |
Osteosarcoma |
|
2020-12-15 |
13x |
Hodgkin lymphoma |
|
2020-12-15 |
7x |
ITP |
|
2020-12-15 |
23x |
Breast cancer |
|
2020-12-15 |
15x |
MDS with excess of blasts (EB-1) |
|
2020-12-15 |
11x |
Chronic neutrophilic leukemia (CNL) |
|
2020-12-15 |
30x |
AML myelomonocytic |
|
2020-12-15 |
11x |
MDS with isolated del(5q) |
|
2020-12-05 |
8x |
atypical Chronic Myeloid Leukemia (a-CML) |
|
2020-12-05 |
24x |
AML with maturation |
|
2020-12-05 |
19x |
Congenital dyserythropoietic anemia (CDA) |
|
2020-10-19 |
10x |
Acute Basophilic Leukemia (ABL) |
|
2020-10-18 |
25x |
Mastocytosis |
|
2020-10-18 |
27x |
Chronic Myelomonocytic Leukemia (CMML) |
|
2020-10-14 |
8x |
Acute Monoblastic Leukemia |
|
2020-10-04 |
21x |
Essential Thrombocytemia (ET) |
|
2020-10-04 |
20x |
Polycythemia Vera (PV) |
|
2020-10-03 |
7x |
dysplasia myelopoiesis |
|
2020-10-03 |
18x |
Hyper Eosinophilic Syndrome / Chronic Eosinophilic Leukemia (HES/CEL) |
|
2020-09-19 |
15x |
thrombotic microangiopathies |
|
2020-09-18 |
11x |
colon carcinoma |
|
2020-09-18 |
10x |
megaloblastic anemia |
|
2020-09-18 |
10x |
Pure red cell aplasia |
|
2020-09-15 |
9x |
Aplastic anemia |
|
2020-09-13 |
5x |
Pelger Huet |
|
2020-09-13 |
4x |
hypersegmentation |
|
2020-09-09 |
24x |
dyserythropoiesis |
|
2020-09-09 |
10x |
MPAL |
|
2020-09-08 |
17x |
MDS with excess of blasts (EB-2) |
|
2020-09-06 |
6x |
renal cell carcinoma |
|
2020-09-05 |
15x |
Gaucher disease |
|
2020-09-05 |
8x |
toxic granulation |
|
2020-08-30 |
100x |
morphology of RBCs |
|
2020-08-30 |
22x |
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) |
|
2020-08-11 |
9x |
osteoclasts & osteoblasts |
|
2020-08-10 |
9x |
Seminoma |
|
2020-08-10 |
15x |
T-cell prolymphocytic leukemia |
|
2020-08-09 |
13x |
leishmaniasis |
|
2020-08-09 |
11x |
persistent-polyclonal-b-cell-lymphocytosis (PPBL) |
|
2020-08-09 |
7x |
Ewing sarcoma |
|
2020-08-08 |
32x |
melanoma |
|
2020-08-04 |
|
differentiating blasts |
|
2020-08-02 |
7x |
normal bone marrow |
|
2020-07-27 |
6x |
MALT lymphoma |
|
2020-07-27 |
37x |
B-ALL |
|
2020-07-26 |
20x |
Hairy Cell Leukemia (HCL) |
|
2020-07-26 |
5x |
cabot rings |
|
2020-07-26 |
11x |
filariasis |